| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on November 15, 2004
Accepted on May 23, 2005
Division of Endocrinology, Diabetes, and Bone Diseases, Department of Medicine, Mount Sinai School of Medicine and Division of Statistical Genetics, Columbia University, New York, NY, USA
* To whom correspondence should be addressed. E-mail: Yaron.Tomer{at}mssm.edu.
Context: Epidemiological data suggest a common genetic susceptibility to Type 1 diabetes (T1D) and autoimmune thyroid disease (AITD).
Objective: To identify the joint susceptibility genes for T1D and AITD.
Design: Family based linkage and association study.
Setting: Academic medical center.
Participants: 55 multiplex families (290 individuals) in which T1D and AITD clustered ("T1D-AITD families").
Main Outcome Measures: Tests for linkage and family-based associations (TDT) with 4 candidate genes, HLA, CTLA-4, insulin VNTR, and thyroglobulin.
Results: Linkage evidence to HLA appeared when subjects with either T1D or AITD were considered affected (MLS=2.2). The major HLA haplotype contributing to the shared susceptibility was DR3-DQB1*0201, with DR3 conferring most of the shared risk. The CTLA-4 gene showed evidence for linkage only when individuals with both T1D+AITD were considered affected (MLS=1.7), and the insulin VNTR showed evidence for linkage when individuals with either T1D or AITD were considered affected (MLS=1.9), i.e. it may contribute to the familial aggregation of T1D and AITD.
Conclusions: The HLA class II locus contributes to the shared risk for T1D and AITD, and the major HLA haplotype contributing to this association is DR3-DQB1*0201. Additional non-HLA loci contribute to the joint susceptibility to T1D and AITD, and two potential candidates include the CTLA-4 and insulin VNTR loci.
This article has been cited by other articles:
![]() |
M. Dittmar, M. Ide, M. Wurm, and G. J Kahaly Early onset of polyglandular failure is associated with HLA-DRB1*03. Eur. J. Endocrinol., July 1, 2008; 159(1): 55 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tsurumaru, E. Kawasaki, H. Ida, K. Migita, A. Moriuchi, K. Fukushima, T. Fukushima, N. Abiru, H. Yamasaki, S. Noso, et al. Evidence for the Role of Small Ubiquitin-Like Modifier 4 as a General Autoimmunity Locus in the Japanese Population J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3138 - 3143. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |